Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2001
10/09/2001US6300332 Methods for reducing respiratory depression and attendant side effects of mu opioid compounds
10/09/2001US6300325 Heterocyclic receptor antagonist
10/09/2001US6300317 Eukarotic cells, polynucleotide, functional agents, membrane permeability, subcellar localization agents and polynucleotide masking agents
10/09/2001US6300314 Admnistering heterocyclic peptides to stimulate hematopoiesis of cells
10/09/2001US6300310 Amino acid sequence with segments of polypeptides
10/09/2001US6300309 Treatment of osteoporosis in mamals with reduced cortical bone mineral density
10/09/2001US6300127 Bone mineralization proteins, DNA, vectors, expression systems
10/09/2001US6299897 Attaching selectin binding carbohydrate to a cross-linkable lipid; attaching an acidic group to a cross linkable lipid; forming lipids into sheet; crosslinking lipids
10/09/2001US6299876 Cytotoxic drug therapy
10/09/2001CA2202057C 5-lipoxygenase inhibitors
10/09/2001CA2123223C Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
10/09/2001CA2119662C New nitrogen bicyclic derivatives, their preparation process and pharmaceutical compositions comtaining them
10/09/2001CA2082825C Inhibition of viral infection
10/07/2001CA2340936A1 Inhibitors for the formation of soluble human cd23
10/04/2001WO2001073115A1 Method and kit for the screening, the detection and/or the quantification of transcriptional factors
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001073002A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001WO2001072993A1 Tlr/cd14 binding inhibitor
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001072841A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072839A2 Human g-protein coupled receptors
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072831A2 Immunoregulator
10/04/2001WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/04/2001WO2001072779A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
10/04/2001WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same
10/04/2001WO2001072771A2 Insulin and igf-1 receptor agonists and antagonists
10/04/2001WO2001072765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING
10/04/2001WO2001072758A1 Tricyclic protein kinase inhibitors
10/04/2001WO2001072756A1 Prodrugs of imidazopyridine derivatives
10/04/2001WO2001072752A2 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS
10/04/2001WO2001072749A1 Condensed pyrazole derivatives, process for producing the same and use thereof
10/04/2001WO2001072745A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders
10/04/2001WO2001072730A1 Selective preventives/remedies for progressive lesions after organ damage
10/04/2001WO2001072728A2 Novel piperazine derivatives
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072721A2 Synergistic methods and compositions for treating cancer
10/04/2001WO2001072720A1 Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases
10/04/2001WO2001072717A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001WO2001072716A1 An intermediate and process for its synthesis
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072709A1 Naphtalene derivatives and their pharmaceutical use
10/04/2001WO2001072707A2 Carbamate caspase inhibitors and uses thereof
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072699A1 Inhibition of angiogenesis and tumor growth
10/04/2001WO2001072687A1 Diphenyl ether compounds useful in therapy
10/04/2001WO2001072685A2 Polyamine analogues as cytotoxic agents
10/04/2001WO2001072669A2 Therapeutic use of polyhydroxy amine derivates
10/04/2001WO2001072341A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
10/04/2001WO2001072326A1 Use of crf receptor agonists for the treatment or prophylaxis of diseases, for example neurodegenerative diseases
10/04/2001WO2001072324A1 Lactams as inhibitors of a-beta protein production
10/04/2001WO2001072311A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
10/04/2001WO2001072308A1 Composition and method for intervening neuronal death using sulfasalazine
10/04/2001WO2001072301A1 Intracorporeal medicaments for photodynamic treatment of disease
10/04/2001WO2001072297A1 Methods for inhibiting angiogenesis and tumor growth
10/04/2001WO2001072296A1 Method of inhibiting the expression of inflammatory cytokines and chemokines
10/04/2001WO2001072294A2 Method of treating hepatitis delta viral infection
10/04/2001WO2001072291A2 Treatment of movement disorders with metabotropic glutamate receptor antagonist
10/04/2001WO2001072290A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
10/04/2001WO2001072288A2 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
10/04/2001WO2001072283A1 Cationic liposomes
10/04/2001WO2001046144A8 New modulators of dopamine neurotransmission
10/04/2001WO2001043704A8 A skin care composition that mediates cell to cell communication
10/04/2001WO2001036638A8 Polypeptides and nucleic acids encoding same
10/04/2001WO2001034565A3 Protease inhibitors
10/04/2001WO2001032685A3 Gene expression directed by a super-psa promoter
10/04/2001WO2001023563A3 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
10/04/2001WO2001022990A3 Methods related to immunostimulatory nucleic acid-induced interferon
10/04/2001WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use
10/04/2001WO2001021773A3 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
10/04/2001WO2001019955A3 Lysosomal targeting pathway enzymes
10/04/2001WO2001019361A3 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
10/04/2001WO2001013957A3 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
10/04/2001WO2001012214A3 MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)
10/04/2001WO2001005764A3 Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester
10/04/2001WO2001000663A3 Catalytically active recombinant memapsin and methods of use thereof
10/04/2001WO2000042074A9 Anti-ccr4 antibodies and methods of use therefor
10/04/2001WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/04/2001US20010027216 Method for preventing hormone induced adverse effects
10/04/2001US20010027214 Stable and nonhygroscopic salts to form tablets, capsules, powders, etc. suitable for dietary/nutritional humans supplements and a feed supplement for veterinary medicine; high-energy metabolism; cardiovascular systems
10/04/2001US20010027212 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027202 Antitumor and -carcinogenic agents; solid cancers, e.g carcinomas of the lungs, pancreas, thyroid, bladder or color, myeloid disorders, e.g. leukemia or adenomas, e.g villous colon adenoma
10/04/2001US20010027201 Non-systemic control of parasites
10/04/2001US20010027200 PPARgamma modulators
10/04/2001US20010027199 Administering a Tumor Necrosis Factor-alpha inhibitor from the group of metalloproteinase inhibitors, quinolones, corticoids, thalidomide, lazaroides, pentoxyphyllines, hydroxamic and carbocyclic acids; spinal disk hernias
10/04/2001US20010027197 Antiproliverative, -carcinogenic and -tumor agents; mitogenesis-activated protein kinase inhibitors; noncytotoxic; binding with high affinity at the adenosine triphosphate binding site of the kinases
10/04/2001US20010027196 Adenosine receptor ligands and their use in the treatment of disease
10/04/2001US20010027181 Treatment or prophylaxis of ischemic heart disease
10/04/2001US20010027176 Cyclooxygenase inhibitor
10/04/2001US20010027175 Inhibiting tumor necrosis factor-alpha (TNF-a) for treating nerve conditions such as sciatica by administering antiinflammatory agent etanercept or infliximab
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001EP1138771A1 Coffee endo-mannanase
10/04/2001EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
1 ... 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 ... 1564